Cannassure Therapeutics Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
CSURE
IL0001110134
Healthcare Facilities & Services
Sales 2022 | 33.78 128.52 46.11 | Sales 2023 | 11 41.84 15.01 | Capitalization | 4M 15.22M 5.46M |
---|---|---|---|---|---|
Net income 2022 | -5M -19.02M -6.82M | Net income 2023 | -1M -3.8M -1.36M | EV / Sales 2022 | 1,023,292 x |
Net Debt 2022 | 29.96M 114M 40.9M | Net Debt 2023 | 434K 1.65M 592K | EV / Sales 2023 | 403,186 x |
P/E ratio 2022 |
-0.84
x | P/E ratio 2023 |
-2.24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 81.66% |
Managers | Title | Age | Since |
---|---|---|---|
Ada Bar Kama
CEO | Chief Executive Officer | 54 | 22-03-30 |
Nir Peles
CHM | Chairman | 50 | 18-12-03 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 19-06-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shimon Bar-Kama
BRD | Director/Board Member | 71 | 18-12-03 |
Nir Peles
CHM | Chairman | 50 | 18-12-03 |
Varda Kalal
BRD | Director/Board Member | 56 | 22-02-13 |
1st Jan change | Capi. | |
---|---|---|
+31.96% | 272M | |
+33.74% | 261M | |
+49.42% | 194M | |
+44.98% | 131M | |
-28.57% | 121M | |
+115.91% | 119M | |
-42.17% | 119M | |
0.00% | 86.82M | |
+150.00% | 75.33M |